Type I allergy, an IgE antibody triggered hypersensitivity disease, represents a common public health problem affecting about one third of the world´s population. Upon exposure to allergens, IgE ...
Switching to IMVT-1402 extends the head starts Immunovant has already ceded to its rivals. Argenx won FDA approval for ...
Pivotal study in MG met primary endpoint of change from baseline in MG-ADL in AChR+ population at 12 weeks, with a 5.6 point improvement in the ...
Clinical Trials Arena on MSN11d
Seismic Therapeutic doses first healthy participant cohort in Phase I trial of S-1117US-based biotechnology company Seismic Therapeutic has dosed the initial cohort of healthy participants in a randomised Phase ...
Seismic Therapeutic, Inc., the machine learning immunology company, today announced the dosing of the first healthy subject cohort in a Phase 1 clinical trial of S?1117, a novel engineered Fc-fused ...
[113] Bold font denotes the most commonly used measure in diagnostic laboratories. †For molecular diagnosis. Ag: Antigen; CSF: Cerobrospinal fluid; DENV: Dengue virus; JEV: Japanese ...
State Key Laboratory of Common Mechanism Research for Major Disease, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China ...
Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well as neurology. BridGene’s pursuit of undruggable targets is enabled ...
Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...
Department of Neurology and Stroke Center, The first Affiliated Hospital & Clinical Neuroscience Institute, Key Lab of Basic and Translational Research of Pan-vascular Diseases, Jinan University, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback